 |
| Global Glycomics Market Size |
The glycomics market involves the study of the structure and function of
glycans. Glycomics finds applications in developing therapeutic strategies for
diseases including diabetes, cancer, and inflammatory conditions. Glycans play
an important role in various biological recognition phenomena and disease
processes. Advancements in the fields of proteomics and genomics have boosted
research activities in glycobiology, thereby driving the demand for glycomics
instruments, reagents, and other products.
The Global
Glycomics Market Size is estimated to be valued at US$ 1.99 Billion in 2024 and is expected to exhibit a CAGR of 13% over the forecast period
from 2024 to 2031.
Glycomics finds widespread usage in drug discovery
& development for diseases such as cancer, inflammatory disease, and other
rare genetic diseases. Glycans are the major components of antibodies and
vaccines. Detailed glycan analysis is important for developing and
manufacturing biopharmaceuticals. Glycomics tools aid in developing highly
efficient and affordable biotherapeutics and biosimilars.
Key Takeaways
Key players operating in the glycomics market are RayBiotech Life, Inc.,
Shimadzu Corporation, Asparia Glycomics, Agilent Technologies Inc., Thermo
Fisher Scientific, Inc., Bruker Corporation, Merck KgaA, New England Biolabs,
Takara Bio Inc, Waters Corporation, Danaher, Lectenz Bio, GlycoMimetics, Inc.,
Ludger Ltd., GlycoTech Corporation, Glykos, Inc., and Glanbia PLC. These
players are adopting strategies such as acquisitions, partnerships, and new
product launches to expand their market share.
The glycomics market offers new opportunities in the areas of biomarker
discovery, drug testing, and disease diagnostics. Biomarkers identified through
glycomics studies could enable non-invasive or fluid-based diagnostics for
various conditions. Glycomics is also finding increasing applications in drug
development, toxicity testing, pharmacokinetics studies, and personalized
medicine.
North America dominates the global glycomics market, followed by Europe.
However, Asia Pacific is expected to witness the highest growth during the
forecast period. This can be attributed to rising collaborations between
international & regional players, increasing healthcare spending, and growing
focus on R&D activities in countries such as China, India, and Japan.
Market drivers
One of the key drivers for the glycomics market is the increasing R&D
investments made by pharmaceutical and biotechnology companies in glycobiology.
Glycans play an important role in several biological pathways and disease
processes. Understanding carbohydrate functions through glycomics tools is
crucial for developing novel treatment and diagnostic approaches. This has
prompted many players to fund glycomics research.
Market restraints
One of the major restraints for the glycomics market is the complexity of
glycan structures. Unlike nucleic acids and proteins, glycans exhibit extensive
diversities and microheterogeneities, making their analysis challenging. Glycomics
techniques also require specialized training which limits their widespread
adoption. The high costs of instruments and reagents further inhibit the growth
of the glycomics market.
Segment Analysis
The glycomics market is dominated by the disease segment. This segment holds
the largest share as glycomics find major applications in disease diagnostics
and developing therapeutic drugs. Glycomics analysis help in better
understanding of various diseases like cancer, arthritis, cardiovascular
diseases etc at molecular level. Identification of distinct glycan patterns in
various diseases help in developing targeted drugs and biomarkers for disease
diagnostics.
Global Analysis
The North America region holds the largest share in the glycomics market owing
to growing research in life sciences, increasing investments in glycomics, and
well-established healthcare industry and research infrastructure in the region.
The region is anticipated to continue its dominance during the forecast period.
However, Asia Pacific is expected to grow at the fastest pace in the glycomics
market during the forecast period. Rising geriatric population, increasing
healthcare expenditure, improving research infrastructure and economic growth
in emerging economies like China and India are driving the market growth in the
region.
Get More Insights On This Topic: Glycomics
Market